Quick answer: Vitamin D deficiency (serum 25-OH-D below 20 ng/mL) affects approximately 42% of American adults and 70% of adults over 65. Optimal functional levels for immune function, cardiovascular protection, cancer risk reduction, and musculoskeletal health are 50-80 ng/mL — substantially above the conventional “sufficient” threshold of 30 ng/mL. Achieving target levels typically requires 5,000-10,000 IU vitamin D3 daily with vitamin K2 MK-7 (to prevent hypercalcemia from calcium mobilization). Serum monitoring at 8-12 weeks is essential to dose-titrate to therapeutic range.
Vitamin D Is Not a Vitamin: It Is a Steroid Hormone
Vitamin D’s classification as a “vitamin” is a historical artifact from its discovery as a dietary essential for rickets prevention. Functionally, vitamin D3 (cholecalciferol) is a secosteroid — a steroid with a broken B ring — synthesized in skin from 7-dehydrocholesterol upon UVB irradiation (wavelength 290-315 nm), and converted sequentially to 25-hydroxyvitamin D3 (25-OH-D, calcidiol, the storage and measured form) in the liver via CYP2R1, and then to the biologically active 1,25-dihydroxyvitamin D3 (1,25-OH-D, calcitriol) in the kidneys via CYP27B1. Calcitriol acts through the vitamin D receptor (VDR) — a nuclear transcription factor present in virtually every cell type — modulating expression of approximately 2,000-3,000 genes (5-10% of the human genome), making it one of the most pleiotropic hormones in the body.
The VDR is expressed in immune cells (T cells, B cells, macrophages, dendritic cells), brain neurons and astrocytes, cardiac myocytes, pancreatic beta cells, adipocytes, skeletal muscle, intestinal epithelium, and virtually every tissue studied. This ubiquitous receptor distribution explains why vitamin D deficiency has been associated with virtually every chronic disease category — not through a single mechanism but through the systemic dysregulation of thousands of VDR-regulated genes across multiple organ systems.
The Epidemic of Vitamin D Deficiency: Why It Occurs
The human genome evolved under conditions of extensive equatorial sun exposure, with ancestral serum 25-OH-D levels of 40-80 ng/mL based on studies of outdoor populations in Africa and Greenland. The modern epidemic of vitamin D deficiency reflects the mismatch between this evolutionary baseline and contemporary lifestyles:
Geographical latitude. UVB radiation sufficient for vitamin D synthesis (wavelength 290-315 nm) cannot reach the earth’s surface at latitudes above approximately 35° North or South during winter months — this includes the entirety of the continental United States north of Los Angeles, including all of Michigan, from approximately October through March. During this period, no dietary intake or sun exposure can substitute for supplementation. The Holick et al. (2011) research on vitamin D latitude cutoffs demonstrates that Boston residents (42°N) cannot synthesize vitamin D from sun from November through February regardless of time spent outdoors.
Sun avoidance and sunscreen. SPF 30 sunscreen blocks approximately 97% of UVB radiation. Even outdoors, sunscreen-using individuals fail to synthesize meaningful vitamin D. The cultural and medical emphasis on sun avoidance for skin cancer prevention has created a paradox: reduced skin cancer risk (primarily basal and squamous cell) while dramatically increasing systemic vitamin D deficiency with its associated cardiovascular, immune, and cancer risks.
Melanin protection and darker skin tones. Melanin absorbs UVB radiation and reduces vitamin D synthesis efficiency — individuals with darker skin tones require 3-5 times more sun exposure to produce equivalent vitamin D as lighter-skinned individuals. This creates a disproportionate vitamin D deficiency burden in African American and Hispanic populations: NHANES data shows 82% of Black Americans have 25-OH-D below 30 ng/mL. This disparity partially explains higher rates of hypertension, type 2 diabetes, and certain cancers in these populations — vitamin D deficiency is a contributing mechanism, not merely an association.
Obesity and adipose sequestration. Vitamin D3 is highly lipophilic and is sequestered in adipose tissue. Obese individuals (BMI above 30) have approximately 50% lower serum 25-OH-D for equivalent oral intake compared to lean individuals, because vitamin D3 is partitioned into enlarged adipose stores and released slowly. Gastric bypass surgery dramatically increases 25-OH-D levels as adipose tissue is lost, releasing sequestered vitamin D3 — confirming the sequestration mechanism. Obese individuals typically require 2-3 times higher supplemental doses to achieve equivalent serum levels.
Digestive malabsorption. Vitamin D3 is fat-soluble and requires bile acid-mediated micelle formation for intestinal absorption. Conditions that impair fat absorption — celiac disease, Crohn’s disease, bariatric surgery, pancreatic insufficiency, liver disease — reduce vitamin D absorption proportionally. Proton pump inhibitors do not significantly affect vitamin D absorption, but cholestyramine (bile acid sequestrant), orlistat (fat absorption blocker), and mineral oil do.
Genetic variation in VDR and CYP2R1. Approximately 30-40% of the population carries genetic variants in VDR, CYP2R1 (25-hydroxylase), or CYP27B1 (1α-hydroxylase) that reduce the efficiency of vitamin D conversion or signaling — requiring higher serum levels to achieve equivalent biological effect. These individuals may show clinical signs of vitamin D insufficiency despite “normal” serum 25-OH-D levels.
The Optimal Vitamin D Level Debate
The conventional medical threshold of “sufficiency” is 25-OH-D above 30 ng/mL, based primarily on bone health endpoints (prevention of secondary hyperparathyroidism and osteomalacia). The functional medicine and longevity medicine target of 50-80 ng/mL is based on a different set of endpoints — immune function, cardiovascular protection, insulin secretion, cancer risk, and neurocognitive performance — and reflects the serum levels at which the non-calcemic effects of vitamin D (immune modulation, anti-tumor activity, insulin secretion) are maximally activated.
The evidence for the 50-80 ng/mL target: Gorham et al. (2007, American Journal of Preventive Medicine) demonstrated that serum 25-OH-D above 52 ng/mL was associated with 50% lower colorectal cancer risk versus below 13 ng/mL. Lappe et al. (2007, American Journal of Clinical Nutrition — n=1,179, 4-year RCT) showed that vitamin D + calcium supplementation to achieve 25-OH-D above 40 ng/mL reduced all-cancer risk by 60-77% versus placebo. Scragg et al. (2018, JAMA Cardiology — n=5,110, VITAL ancillary study) demonstrated 25-OH-D levels associated with reduced cardiovascular events. The U-shaped curve concern (toxicity at very high levels) becomes relevant above 100-150 ng/mL; the 50-80 ng/mL target is well below any documented toxicity threshold and reflects the range found in outdoor African populations with low chronic disease rates.
The Complete Vitamin D Deficiency Protocol
Step 1: Test, don’t guess. Order serum 25-OH-D (available via standard labs — Quest, LabCorp — or direct-to-consumer through Walk-In Lab and similar services). Results interpretation: below 20 ng/mL = deficient (clinical disease risk); 20-30 ng/mL = insufficient (suboptimal bone and immune effects); 30-50 ng/mL = conventional sufficiency but below functional target; 50-80 ng/mL = functional optimal range; above 100 ng/mL = potential hypercalcemia risk with prolonged high-dose supplementation; above 150 ng/mL = toxicity threshold (hypercalcemia, hypercalciuria, soft tissue calcification). Also test serum calcium, PTH (parathyroid hormone, which is suppressed by vitamin D), and phosphorus to complete the calcium-vitamin D axis assessment.
Step 2: Dose based on current level and target. The general rule for dose-response: each 1,000 IU of daily vitamin D3 raises serum 25-OH-D by approximately 3-5 ng/mL in average-weight individuals over 8-12 weeks. Obese individuals may see only 1-2 ng/mL rise per 1,000 IU. Starting recommendations by baseline level: below 20 ng/mL → 8,000-10,000 IU/day for 12 weeks, then retest and transition to maintenance; 20-30 ng/mL → 5,000-8,000 IU/day for 12 weeks, retest; 30-50 ng/mL → 4,000-5,000 IU/day for 12 weeks, retest; maintenance at target range → 2,000-5,000 IU/day depending on sun exposure, season, and individual response. High-dose loading protocols (50,000-100,000 IU weekly for 8 weeks) can achieve target levels faster but require closer monitoring.
Step 3: Always combine with vitamin K2 MK-7 (100-200 mcg/day). Vitamin D3 increases intestinal calcium absorption and calcium mobilization from bone. Without adequate vitamin K2 (the carboxylated form that activates matrix Gla protein and osteocalcin), the mobilized calcium cannot be properly directed into bone (osteocalcin-mediated mineralization) and may deposit in soft tissues — a mechanism proposed to explain some cases of arterial calcification in high-dose D supplementation. Vitamin K2 MK-7 (menaquinone-7, the long-acting form from natto) activates matrix Gla protein (MGP) to prevent vascular calcification and activates osteocalcin for bone mineralization. The D3 + K2 MK-7 combination is the standard of care in vitamin D supplementation — K2 MK-7 does not interfere with warfarin metabolism (MK-4 has fewer interactions as well, but MK-7 is now generally considered safe with monitoring).
Step 4: Optimize cofactors. Magnesium is a cofactor for both CYP2R1 (hepatic 25-hydroxylase) and CYP27B1 (renal 1α-hydroxylase) — the two enzymes required to convert vitamin D3 to its active form. Magnesium deficiency impairs vitamin D activation and explains why some individuals show minimal response to vitamin D supplementation. Rosanoff et al. (2016, Journal of the American Osteopathic Association) demonstrated that magnesium supplementation improved vitamin D effectiveness and reduced both vitamin D supplementation dose requirements and supplementation-associated toxicity risk. Zinc is a cofactor for VDR-mediated transcription. Boron reduces urinary calcium excretion and increases 25-OH-D half-life. The complete cofactor support: magnesium glycinate 300-400 mg/day, zinc 15-25 mg/day, boron 3-6 mg/day.
Step 5: Retest at 8-12 weeks. Follow-up 25-OH-D testing confirms therapeutic response and guides dose adjustment. The 8-12 week interval is necessary because the half-life of 25-OH-D is approximately 2-3 weeks — steady-state levels are reached in 8-12 weeks of consistent supplementation. Continue annual monitoring at the same season (spring testing reflects winter trough; fall testing reflects summer peak). For individuals on doses above 5,000 IU/day, also test calcium and PTH at each monitoring visit to ensure no hypercalcemia development.
Frequently Asked Questions
Q: Can I get enough vitamin D from sunlight alone?
In theory yes — 20-30 minutes of midday sun exposure (10 AM to 2 PM) on arms, legs, and torso without sunscreen can generate 10,000-20,000 IU of vitamin D3 in light-skinned individuals at appropriate latitudes during summer months. However, practical limitations make sunlight alone insufficient for most people: latitude (most Americans cannot synthesize vitamin D from sun for 4-6 months annually), skin tone (darker-skinned individuals require 3-5× longer exposure), age (synthesis declines 50-70% between ages 20 and 70 due to reduced 7-dehydrocholesterol in aging skin), lifestyle (most adults spend less than 30 minutes outdoors during peak UVB hours), and sunscreen use. Supplementation is the reliable, year-round solution for most people north of Atlanta, Georgia.
Q: What is the difference between vitamin D2 and D3?
Vitamin D2 (ergocalciferol) is plant/fungi-derived; vitamin D3 (cholecalciferol) is animal-derived (from lanolin or fish liver). D3 is the physiologically produced human form. Multiple comparative studies (Tripkovic et al., 2012, American Journal of Clinical Nutrition — meta-analysis) demonstrate D3 is 87% more potent at raising and maintaining serum 25-OH-D than D2 at equivalent doses. D3 also has a longer half-life and better conversion efficiency. Prescription high-dose vitamin D (50,000 IU) is typically vitamin D2 in the US — this is a historical artifact. Vitamin D3 supplements at equivalent or higher doses are more effective for raising serum levels. For supplementation, D3 is preferred.
Q: Can vitamin D supplementation prevent COVID-19 or upper respiratory infections?
Vitamin D’s role in immune function is well established — the VDR in macrophages and T cells regulates cathelicidin (an antimicrobial peptide), cytokine production, and T regulatory cell differentiation. Multiple meta-analyses including Martineau et al. (2017, BMJ — 25 RCTs, n=11,321) demonstrated vitamin D supplementation significantly reduced acute respiratory tract infection risk (OR 0.88, 95% CI 0.81-0.96), with the strongest effect in those who were severely deficient at baseline. COVID-19 specifically: deficiency (below 20 ng/mL) was associated with increased severity and mortality in multiple observational studies. RCT evidence for treatment is mixed, with the CORONADO study and subsequent analyses suggesting benefit primarily in deficient individuals. The public health conclusion: vitamin D sufficiency (above 40 ng/mL) is likely protective against respiratory infection severity; correction of deficiency is appropriate regardless of pandemic concerns.
If you are experiencing fatigue, recurrent infections, bone or muscle pain, mood disturbances, or simply want to optimize your vitamin D status for long-term health, contact our office at (810) 206-1402 to discuss comprehensive vitamin D testing, optimal dosing for your individual factors, and the complete D3/K2/magnesium cofactor protocol.
Related Reading
- What Your Vitamin D Level Actually Means (And Why 30 ng/mL Is Not Enough)
- The 5 Lab Tests Every Person Over 35 Should Demand From Their Doctor
- Insulin Resistance: Why 40% of Adults Have It and Don’t Know It
Dive Deeper
- Vitamin D: Optimal Levels, Deficiency Signs, and the Complete Supplementation Protocol
- Vitamin D & Longevity: The Hormone-Vitamin That 42% of Americans Are Deficient In
- What Your Vitamin D Level Actually Means (And Why 30 ng/mL Is Not Enough)
- Magnesium Deficiency: The Most Overlooked Reason You Feel Terrible
- Zinc Deficiency: Immunity, Testosterone, Wound Healing, and the Supplementation Protocol